Home › Funds › Opaleye Management Inc. › RCKT

Opaleye Management Inc. position in RCKT

ROCKET PHARMACEUTICALS INC · Health Care

Opaleye Management Inc. reported holding 1,000,000 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.4M, representing 0.31% of its reported portfolio and ranking #41 among its reported holdings. Opaleye Management Inc. has disclosed RCKT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.00M sh
Reported value held$3.42M
Portfolio Weight0.31%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s RCKT position evolved

Opaleye Management Inc. first disclosed a stake in RCKT in Q4 2025 at 955,000 shares (US$3.4M). The position peaked in Q2 2026 at 1,000,000 shares, worth US$3.4M. Across 3 filings, Opaleye Management Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,000,000 shares valued at US$3.4M — an increase of 45,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 955.00K $3.35M New
Q1 2026 955.00K $3.42M Hold
Q2 2026 1.00M $3.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCKT and 13F data

RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 19 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$60.5M), Newtyn Management, LLC (US$13.7M), Maverick Capital (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCKT

All RCKT fund holders →

FAQ

How long has Opaleye Management Inc. held RCKT?

Opaleye Management Inc. has disclosed RCKT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Opaleye Management Inc.'s current position in RCKT?

As of Q2 2026, Opaleye Management Inc. holds 1.00M shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $3.42M, representing 0.31% of its reported portfolio and ranking #41.

Has Opaleye Management Inc. been buying or selling RCKT?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. increased its position in RCKT. The position peaked in Q2 2026 at 1.00M shares.

Which other funds hold RCKT?

Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Newtyn Management, LLC, Maverick Capital, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.